SutroVax Inc. Funding & Investors
SutroVax is a recently established biopharmaceutical company developing vaccines for infectious disease targets with an initial emphasis on best-in-class conjugate vaccines and protein-based vaccines.
sutrovax.comTotal Amount Raised: $1,484,540,032
SutroVax Inc. Funding Rounds
Post Ipo Equity
$500,000,000
Post Ipo Equity
$600,000,000
Post Ipo Equity
$100,000,000
Grant
$3,200,000
Grant Investors
CARB-XGrant
$2,700,000
Grant Investors
CARB-XSeries D
$110,000,000
Series D Investors
AbingworthFrazier ManagementTPG GrowthRoche Venture FundLongitude CapitalHenderson Global InvestorsForesite CapitalRA Capital ManagementPivotal bioVenture PartnersMedicxiCTI Life Sciences FundGrant
$1,640,000
Grant Investors
CARB-XSeries C
$85,000,000
Series C Investors
AbingworthTPG GrowthRoche Venture FundForesite CapitalMedicxiSeries B
$60,000,000
Series B Investors
AbingworthFrazier ManagementLongitude CapitalRoche Venture FundPivotal bioVenture PartnersCTI Life Sciences FundSeries A
$22,000,000
Series A Investors
AbingworthLongitude CapitalRoche Venture FundCTI Life Sciences Fund
Funding info provided by Diffbot.